Certified by Founder Lodge
ImmunoScape
Singapore - Singapore
START UP
1 Disclosed Funding Rounds $14,000,000
0 Participating Investments
-
Founded date
2016
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
ImmunoScape is a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR cell therapies in the field of oncology. The company's proprietary Deep Imm
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 26 ,2022 | Unknown | $14,000,000 |
Anzu Partners
Amgen
EDBI Pte Ltd
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Bubble Robotics | $5,000,000 | (Apr 23, 2026)
Schematic | $6,500,000 | (Apr 23, 2026)
C-Infinity | $16,000,000 | (Apr 23, 2026)
Omeza | $8,500,000 | (Apr 23, 2026)
Mosaic(US) | $18,000,000 | (Apr 23, 2026)
